BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32690953)

  • 1. Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1.
    Volcic M; Sparrer KMJ; Koepke L; Hotter D; Sauter D; Stürzel CM; Scherer M; Stamminger T; Hofmann TG; Arhel NJ; Wiesmüller L; Kirchhoff F
    Nat Microbiol; 2020 Oct; 5(10):1247-1261. PubMed ID: 32690953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.
    Xu Z; Lodge R; Power C; Cohen EA; Hobman TC
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.
    Emeagwali N; Hildreth JE
    Virol J; 2012 Nov; 9():277. PubMed ID: 23164059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
    Sauter D; Kirchhoff F
    Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses.
    Langer S; Hammer C; Hopfensperger K; Klein L; Hotter D; De Jesus PD; Herbert KM; Pache L; Smith N; van der Merwe JA; Chanda SK; Fellay J; Kirchhoff F; Sauter D
    Elife; 2019 Feb; 8():. PubMed ID: 30717826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
    Sugden SM; Pham TNQ; Cohen ÉA
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.
    Lambelé M; Koppensteiner H; Symeonides M; Roy NH; Chan J; Schindler M; Thali M
    J Virol; 2015 Mar; 89(6):3247-55. PubMed ID: 25568205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpu does not degrade interferon regulatory factor 3.
    Hotter D; Kirchhoff F; Sauter D
    J Virol; 2013 Jun; 87(12):7160-5. PubMed ID: 23552418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.
    Mi Z; Ding J; Zhang Q; Zhao J; Ma L; Yu H; Liu Z; Shan G; Li X; Zhou J; Wei T; Zhang L; Guo F; Liang C; Cen S
    Sci Rep; 2015 Dec; 5():18499. PubMed ID: 26669976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Triggers a cGAS-Dependent, Vpu- and Vpr-Regulated Type I Interferon Response in CD4
    Vermeire J; Roesch F; Sauter D; Rua R; Hotter D; Van Nuffel A; Vanderstraeten H; Naessens E; Iannucci V; Landi A; Witkowski W; Baeyens A; Kirchhoff F; Verhasselt B
    Cell Rep; 2016 Oct; 17(2):413-424. PubMed ID: 27705790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
    Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
    J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.
    Doehle BP; Chang K; Rustagi A; McNevin J; McElrath MJ; Gale M
    J Virol; 2012 Aug; 86(16):8367-74. PubMed ID: 22593165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vpu Protein: The Viroporin Encoded by HIV-1.
    González ME
    Viruses; 2015 Aug; 7(8):4352-68. PubMed ID: 26247957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
    Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
    J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.